Stereotactic Radiotherapy for Treatment of Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration
Tóm tắt
Age-related macular degeneration (AMD) is the leading cause of visual loss among adults 65 years and older in western countries. Of patients with AMD who experience severe loss of vision, approximately 90% do so because of choroidal neovascularization (CNV). Visual loss is most severe when the CNV occurs directly under the fovea. Radiation-treated patients show some stabilization of visual acuity and reduction in extent of CNV compared to similar patients managed by observation alone. Various external beam radiation field arrangements were used to deliver the radiation treatments. The stereotactic radiation delivery technique employed in this study allows precise delivery of radiation to the target with much less radiation delivered to nearby sensitive structures (i.e., lens, optic nerves, optic chiasm, and contralateral eye). This aim of this paper is to describe our stereotactic technique for treatment of CNV, and the method we used for target definition and eye immobilization. We also compare the stereotactic technique with other techniques reported in the literature with regard to dose distributions, dose-volume histograms, and normal tissue complication probabilities (NTCP). We found that the position of the eye can be reproduced from one treatment fraction to the next, that the target can be localized accurately, and that stereotactic radiotherapy minimizes the dose to adjacent and surrounding normal structures while providing a homogeneous dose to the target area.
Tài liệu tham khảo
Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al.: The Framingham Eye Study Monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 24(suppl):335–610, 1980
Klein R, Klein BE, Linton KL: Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 99:933–943, 1992.
Ferris FL, Fine SL, Hyman L: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102:1640–1642, 1984
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 109:1242–1257, 1991
Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 100:912–918, 1982
Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 108:816–824, 1990
Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Arch Ophthalmol 109:1220–1231, 1991
Thomas MA, Dickinson JD, Melberg NS, Ibanez HE, Dhaliwal RS: Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 101:1384–1396, 1994
Machemer R, Steinhorst UH: Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefe's Arch Clin Exp Ophthalmol 231:635–641, 1993
Algvere PV, Berglin L, Gouras P, Sheng Y: Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Grafe's Arch Clin Exp Ophthalmol 232:707–716, 1994
Chan CK, Kempin SJ, Noble SK, Palmer GA: The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study. Ophthalmology 101:289–300, 1994
Thomas MA, Ibanez HE: Interferon alpha-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophthalmol 115:563–568, 1993
Poliner LS, Tornambe PE, Michelson PE, Heitzmann JG: Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration. Ophthalmology 100:1417–1424, 1993
D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide as an inhibitor of angiogenesis. Proc National Acad Sci USA 91:4082–4085, 1994
Chakravarthy U, Houston RF, Archer DB: Treatment of age-related subfoveal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 77:265–273, 1993
Bergink GJ, Deutman AF, van den Broek JF, van Daal WA, van der Maazen RW: Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration: A pilot study. Grafe's Arch. Clin Exp Ophthalmol 232:591–598, 1994
Valmaggia C, Bischoff P, Ries G: Low dosage radiotherapy of subfoveal neovascularization in age-related macular degeneration. Preliminary results. Klin Monatsbl Augenheilkd 206:343–346, 1995
Hart PM, Archer DB, and Chakravarthy U: Asymmetry of disciform scarring in bilateral disease when one eye is treated with radiotherapy. Br J Ophthalmol 79:562–568, 1995
Brady LW, Freire JE, Longton WA, Miyamoto CT, Augsburger JJ, Brown GC, et al.: Radiation therapy for macular degereration: Technical considerations and preliminary results. Int J Radiat Oncol Biol Phys 39:945–948, 1997
Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Boswoth JL: Radiation therapy for subretinal neovascularization. Ophthalmology 103:878–889, 1996
Gill SS, Thomas DGT, Warrington AP, Brada M: N Relocatable frame for stereotactic external beam raditherapy. Radiat Biol Phys 20:599–603, 1991
Graham JD, Warrington AP, Gill SS, Brada M: A non-invasive, relocatable stereotactic frame for fractionated radiotherapy and multiple imaging. Radiother Oncol 21:60–62, 1991
International Commission on Radiation Units and Measurements: Prescribing, Recording, and Reporting Photon Beam Therapy, ICRU Report 50. Bethesda, MD, 1992
Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R: Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluation. Int J Radiat Oncol Biol Phys 21:137–146, 1991
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenider JC, et al.: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122, 1991